Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
ClavystBio launches to translate life sciences breakthroughs into health impact 2022-09-15 10:00
Juniper Biologics Establishes Global Headquarters in Singapore 2022-09-15 09:53
Data from KN046 in Patients with metastatic NSCLC who failed first line treatment or prior EGFR-TKIs Presented at ESMO 2022 2022-09-14 09:11
Alphamab Oncology Presents the updated data from Phase 2 Clinical trial on KN046 Combined with platinum doublet chemotherapy as first-line（1L）treatment for NSCLC at ESMO 2022 2022-09-14 09:04
Updated Data Presented for KN026 comboKN046 in 1st Line HER2-Positive Gastric/Gastroesophageal Junction Cancer (GC/GEJ) 2022-09-14 09:01
Antengene Unveils Its First Australian Office to Continue Expanding Global Presence 2022-09-14 08:30
Debiopharm Co-leads a 10M USD Series A Round to Accelerate the Development of Genomic Medicines through Artificial Intelligence 2022-09-14 00:48
TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism 2022-09-13 22:15
AnBogen Therapeutics Receives Approval from U.S. FDA for Phase Ib/II Protocol Amendment for ABT-101 2022-09-13 22:00
Turn Biotechnologies launches eTurna™ delivery platform designed specifically to enable nucleic acid therapeutics 2022-09-13 20:38
AO Foundation acquires RIMASYS to advance the surgical education ecosystem of the future 2022-09-13 18:00
TikoMed's ILB(R) inhibits cell infection by coronaviruses and modulates reactive cytokine release from microglia in vitro 2022-09-13 16:08
Transcenta Releases Encouraging Interim Safety and Efficacy Data of the TST001 (Osemitamab) and Chemotherapy Combination Expansion Cohort for First Line Claudin18.2 Positive Gastric Cancer at ESMO Congress 2022 2022-09-13 08:00
Aldatu Biosciences Adds Another Outbreak Disease to Pandemic Preparedness Portfolio 2022-09-13 00:33
DarwinHealth Publication Reports Step-by-Step Protocol for its Tumor Checkpoint-Based, Compound-to-Clinic (C2C) Cancer Drug Discovery Pipeline: Elucidates a Patient-to-Model-to-Patient (PMP) Roadmap for Precision- and Mechanism-Based Identification and Clinical Validation of Novel, Investigational and FDA-Approved Therapeutic Agents Targeting Tumor Regulatory Architecture 2022-09-13 00:26
EpiVax Secures Additional Funding from FDA for Immunogenicity Risk Assessment for Biosimilar Products 2022-09-13 00:24
Himalaya Therapeutics Announces Interim Phase 2 Results for Mecbotamab vedotin (HTBA3011) 2022-09-12 23:32
Brain Navi Biotechnology Announced Partnership with Distributor, Medtreq Medical Equipment, to enter the Middle East and Egypt with NaoTrac Neurosurgical Robot 2022-09-12 08:31
MGI Celebrates Grand Opening of Its New State-of-the-Art Demo Lab in Japan 2022-09-09 09:00
KAZIA TO PRESENT FINAL DATA FROM PAXALISIB PHASE II STUDY IN GLIOBLASTOMA AT ESMO 2022-09-09 06:00
1 62 63 64 65 66 212